However, the choice of striking criteria finalized to exclude the DVT patients who already had known genetic (e.g., FV Leiden and prothrombin G20210A mutations) or environmental risk factors for DVT, contributed to magnify the power. This evidence concerns the gene F5 and deep vein thrombosis.